Cargando…

Unexpected Neurological Symptoms of Ruxolitinib: A Case Report

Ruxolitinib is a highly potent JAK2 inhibitor approved for the treatment of myelofibrosis (idiopathic or post-polycythemia vera or post-essential thrombocythemia) and, more recently, for polycythemia vera with an inadequate response to or intolerant of hydroxyurea. The most common adverse events of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Furia, Francesca, Canevini, Maria P., Federici, Augusto B., Carraro, Maria C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665860/ https://www.ncbi.nlm.nih.gov/pubmed/33224394 http://dx.doi.org/10.14740/jh642

Ejemplares similares

A case of modern management of Morgagni‐Adam‐Stokes syndrome
por: Negroni, Maria Silvia, et al.
Publicado: (2019)

Ruxolitinib: Thrombocytopenia following compassionate use of ruxolitinib: 2 case reports
Publicado: (2022)

Ruxolitinib: Extreme thrombocytosis: case report
Publicado: (2021)

Ruxolitinib: Viral respiratory infections: case report
Publicado: (2019)

Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib
por: Pálmason, Róbert, et al.
Publicado: (2015)

Ruxolitinib found to cause eyelash growth: a case report
por: Song, Julia, et al.
Publicado: (2017)

Ruxolitinib improves symptoms and quality of life in a patient with systemic mastocytosis
por: Yacoub, Abdulraheem, et al.
Publicado: (2016)

Precision treatment of Singleton Merten syndrome with ruxolitinib: a case report
por: Broser, Philip, et al.
Publicado: (2022)

Ruxolitinib: Immunosuppression leading to impaired viral RNA clearance: case report
Publicado: (2021)

Methylprednisolone/prednisolone/ruxolitinib: Masked fever and lack of efficacy: case report
Publicado: (2022)

Depression, extrapyramidal symptoms, dementia and an unexpected outcome: a case report
por: Tsolaki, Magda, et al.
Publicado: (2010)

Ruxolitinib in steroid refractory graft-vs.-host disease: a case report
por: Maffini, Enrico, et al.
Publicado: (2016)

Cryptococcal infection with ruxolitinib in primary myelofibrosis: A case report and literature review
por: Ciochetto, Zachary, et al.
Publicado: (2022)

A Case of Hepatitis E Persistence in a Patient With Myelofibrosis Under Ruxolitinib
por: Ribeiro da Cunha, Maria, et al.
Publicado: (2021)

Ruxolitinib: Grade 3 liver toxicity following off-label use: case report
Publicado: (2020)

Ruxolitinib: Rebound effect manifested as acute hypoxaemic respiratory failure: 3 case reports
Publicado: (2021)

Unexpected rapid symptom response after praziquantel to intestinal Schistosoma mansoni symptoms: A case report from Rwanda
por: Sibomana, Jean Pierre, et al.
Publicado: (2023)

Topical ruxolitinib for the treatment of granuloma faciale
por: Wong, Alan, et al.
Publicado: (2023)

Ruxolitinib cream for the treatment of cutaneous sarcoidosis
por: Smith, Jeffrey S., et al.
Publicado: (2023)

A case report of disseminated histoplasmosis and concurrent cryptococcal meningitis in a patient treated with ruxolitinib
por: Prakash, Katya, et al.
Publicado: (2019)

Ruxolitinib Treatment During Myelofibrosis Leads to Cutaneous Mycobacterium marinum Infection: A Case Report
por: Chen, Xiaonan, et al.
Publicado: (2023)

Severe ARDS due to Ruxolitinib discontinuation syndrome: case presentation and literature review
por: Houthuys, Jona F., et al.
Publicado: (2022)

Development of sebaceous carcinoma in a patient on ruxolitinib therapy
por: Mohsin, Noreen, et al.
Publicado: (2022)

Delayed granulomatous eruption of the nose associated with ruxolitinib
por: Brown, Margaret, et al.
Publicado: (2020)

Treatment of cutaneous lupus with topical ruxolitinib cream
por: Park, Jonathan J., et al.
Publicado: (2022)

Ruxolitinib for severe fever with thrombocytopenia syndrome (SFTS)
por: Wen, Sai, et al.
Publicado: (2022)

Ruxolitinib Treatment in a Patient with Primary Myelofibrosis Resistant to Conventional Therapies and Splenectomy: A Case Report
por: Aylı, Meltem, et al.
Publicado: (2015)

Ruxolitinib as an Effective Treatment for Hemophagocytic Lymphohistiocytosis Secondary to SARS-Cov-2 Infection: A Case Report
por: Wang, Lina, et al.
Publicado: (2023)

The unexpected epidural: a case report
por: Pinciroli, Riccardo, et al.
Publicado: (2015)

Unexpected extrapyramidal symptoms and pulmonary aspergillosis in exertional heatstroke with fulminant liver failure: a case report
por: Jiao, Jie, et al.
Publicado: (2017)

A case of trichodysplasia spinulosa related to ruxolitinib treated successfully with oral acitretin
por: Rosa‐Nieves, Priscilla M., et al.
Publicado: (2023)

Cryptococcal fungemia and Mycobacterium haemophilum cellulitis in a patient receiving ruxolitinib: a case report and literature review
por: Sayabovorn, Naruemit, et al.
Publicado: (2021)

Abatacept/immunosuppressants/ruxolitinib: Various toxicities following off-label use and lack of efficacy: 20 case reports
Publicado: (2022)

Ruxolitinib as Adjunctive Therapy for Hemophagocytic LymPhohistiocytosis after Liver Transplantation: A Case Report and Literature Review
por: He, Kang, et al.
Publicado: (2022)

Tuberculosis Peritonitis During Treatment of Polycythemia Vera with Ruxolitinib
por: Sakiyama, Emiko, et al.
Publicado: (2020)

Ruxolitinib is effective in the treatment of a patient with refractory T‐ALL
por: Jaramillo, Sonia, et al.
Publicado: (2020)

Ruxolitinib Associated Tuberculosis Presenting as a Neck Lump
por: Shamil, Eamon, et al.
Publicado: (2015)

Reactivation of Pulmonary Tuberculosis following Treatment of Myelofibrosis with Ruxolitinib
por: Abidi, Maheen Z., et al.
Publicado: (2016)

Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib
por: Sandhu, Sunny, et al.
Publicado: (2022)

Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis
por: Pope, Eleanor, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_117fbt6p8jc38ol97veb7nsqp7